[{"address1": "9350 Kirby Drive", "address2": "Suite 300", "city": "Houston", "state": "TX", "zip": "77054", "country": "United States", "phone": "713 400 6400", "website": "https://markertherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Ms. Elizabeth  Donnelly", "title": "Director of Administration", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edmund  Cheung", "title": "Vice President of Human Resources", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Nadia  Agopyan Ph.D.", "title": "Senior Vice President of Regulatory Affairs", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Monic  Stuart M.D.", "title": "Chief Medical Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Patricia  Allison", "title": "Head of Clinical Operations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael J. Loiacono", "age": 57, "title": "Secretary", "yearBorn": 1966, "fiscalYear": 2018, "totalPay": 287981, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert Z. Florkiewicz Sr.", "title": "Senior Director of Molecular Biology & Virology", "fiscalYear": 2018, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1546214400, "maxAge": 86400, "priceHint": 4, "previousClose": 4.5, "open": 4.495, "dayLow": 4.3316, "dayHigh": 4.57, "regularMarketPreviousClose": 4.5, "regularMarketOpen": 4.495, "regularMarketDayLow": 4.3316, "regularMarketDayHigh": 4.57, "beta": 1.543, "forwardPE": -1.2838234, "volume": 3373, "regularMarketVolume": 3373, "averageVolume": 18579, "averageVolume10days": 14580, "averageDailyVolume10Day": 14580, "bid": 3.17, "ask": 5.73, "bidSize": 200, "askSize": 200, "marketCap": 38861156, "fiftyTwoWeekLow": 0.76, "fiftyTwoWeekHigh": 9.68, "priceToSalesTrailing12Months": 11.736513, "fiftyDayAverage": 4.2756, "twoHundredDayAverage": 4.4517, "currency": "USD", "enterpriseValue": 23749696, "profitMargins": -2.48761, "floatShares": 6746882, "sharesOutstanding": 8902900, "sharesShort": 64427, "sharesShortPriorMonth": 149703, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.0072000003, "heldPercentInsiders": 0.12167, "heldPercentInstitutions": 0.22950001, "shortRatio": 2.89, "shortPercentOfFloat": 0.0101, "impliedSharesOutstanding": 8974280, "bookValue": 1.58, "priceToBook": 2.762658, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -14045895, "trailingEps": -1.59, "forwardEps": -3.4, "lastSplitFactor": "1:10", "lastSplitDate": 1674777600, "enterpriseToRevenue": 7.173, "enterpriseToEbitda": -2.014, "52WeekChange": 4.202381, "SandP52WeekChange": 0.21080327, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "MRKR", "underlyingSymbol": "MRKR", "shortName": "Marker Therapeutics, Inc.", "longName": "Marker Therapeutics, Inc.", "firstTradeDateEpochUtc": 1026826200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f52316f7-d523-378a-bebe-a89c89d1c289", "messageBoardId": "finmb_1725474", "gmtOffSetMilliseconds": -14400000, "currentPrice": 4.365, "targetHighPrice": 12.5, "targetLowPrice": 12.5, "targetMeanPrice": 12.5, "targetMedianPrice": 12.5, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 15111450, "totalCashPerShare": 1.697, "ebitda": -11792272, "quickRatio": 5.249, "currentRatio": 5.57, "totalRevenue": 3311133, "revenuePerShare": 0.376, "returnOnAssets": -0.35358003, "returnOnEquity": -0.83472997, "freeCashflow": -10140911, "operatingCashflow": -16439961, "revenueGrowth": 0.392, "grossMargins": -2.14599, "operatingMargins": -2.7806, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-26"}]